Related Experiment Videos
Are there benefits from long-term pharmacotherapy of obesity?
Archives of Internal Medicine
|May 9, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Genetic-Proteomic Integration Identifies Predictive Plasma Proteins for Multiple Sclerosis.
Annals of neurology·2026
Morbidity and mortality outcomes of surgical versus transcatheter aortic valve replacement in patients dependent on dialysis.
The Journal of thoracic and cardiovascular surgery·2026
Assessment of ChatGPT's performance on neurology written board examination questions.
BMJ neurology open·2023
A National Survey of Perspectives of Physician Assistants in Academic Plastic and Reconstructive Surgery.
Plastic and reconstructive surgery. Global open·2023
Efficacy and Safety of CagriSema for Metabolic Outcomes: Systematic Review and Pairwise Meta-Analysis of Randomized Controlled Trials.
Diabetes, metabolic syndrome and obesity : targets and therapy·2026
A phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of sipavibart in healthy Japanese adults.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
Central Nervous System Effects of GLP-1 Receptor Agonists: A Systematic Review of Human Neuroimaging Studies.
Neuroscience and biobehavioral reviews·2026
Methylphenidate-Based Interventions for Depressive Symptoms in Palliative Care: A Systematic Review and Meta-Analysis.
Journal of pain and symptom management·2026
Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.
Seminars in oncology·2026